Galapagos NV Anteile 2011-2026 | GLPG

Anteile Jährlich Galapagos NV

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	65.5 M	65.1 M	57.6 K	52.1 M	49.5 M	944 M	35.7 M	30.1 M	28.8 M	26.5 M	-

Alle Zahlen in EUR-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
944 M	57.6 K	130 M

Anteile anderer Aktien in der Pharmaeinzelhändler

Name	Anteile	Preis	% 24h	Marktkapitalisierung	Land
Acorda Therapeutics ACOR	1.24 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	19.8 M	-	-	$ 86.2 M	USA
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
Burford Capital Limited BUR	219 M	$ 4.73	0.42 %	$ 761 M	Britain
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	131 M	$ 333.39	-1.77 %	$ 43.7 B	USA
Can-Fite BioPharma Ltd. CANF	1.65 M	$ 3.17	3.93 %	$ 5.22 M	Israel
Applied Molecular Transport AMTI	38.8 M	-	-	$ 10.1 M	USA
I-Mab IMAB	220 M	-	-	$ 866 M	China
Alterity Therapeutics Limited ATHE	2.41 B	$ 3.73	3.04 %	$ 8.97 B	Australia
AlloVir ALVR	15.3 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	9.88 M	$ 7.42	-15.1 %	$ 73.3 M	USA
Allakos ALLK	86.8 M	-	-	$ 28.6 M	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	84.2 M	-	-	$ 8.42 M	USA
Aptinyx APTX	67.7 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	36.4 M	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	9.27 M	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	46.7 M	$ 21.68	1.4 %	$ 1.01 B	USA
Cabaletta Bio CABA	100 M	$ 3.4	4.29 %	$ 342 M	USA
CymaBay Therapeutics CBAY	106 M	-	-	$ 3.45 B	USA
BioNTech SE BNTX	244 M	$ 99.47	1.08 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	10.2 M	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	521 K	-	-5.16 %	$ 5.39 M	USA
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	257 M	-	-	$ 399 M	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	107 M	$ 4.24	2.17 %	$ 453 M	USA
Arcutis Biotherapeutics ARQT	127 M	$ 24.58	-2.03 %	$ 3.13 B	USA
AIkido Pharma AIKI	14.3 M	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	99.3 M	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	266 M	$ 1.49	0.68 %	$ 397 M	Britain
Aptose Biosciences APTO	2.45 M	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	1.42 B	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	39.7 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	8.33 M	-	-16.75 %	$ 25.8 M	USA
Celldex Therapeutics CLDX	66.4 M	$ 33.87	1.62 %	$ 2.25 B	USA
AVROBIO AVRO	44.3 M	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	61.8 M	-	-	$ 25.3 M	USA
bluebird bio BLUE	110 M	-	-	$ 546 M	USA
AstraZeneca PLC AZN	1.42 B	-	-	$ 96.9 B	Britain
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA